Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mannitol Effect on Recovery After Orthognathic Surgery
NCT06400355Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Mar 2024
- Primary completion
- Jun 2024
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Bronchitol (2 arms), sponsored by National Cancer Institute. Primary endpoint: Time to extubation. Started Mar 2024; status: active, not recruiting.
02
Drugs
Bronchitol
Beyond the preview
Go deeper on NCT06400355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06400355.